SSR-162329

N/A

Report date: 2022/08/23 20:00:44
NME

Base Information

Drug NameSSR-162329
Drug Alias NameSR-162329
ClassificationOther
Mechanisms of ActionDipeptidyl peptidase IV inhibitors
TargetsDipeptidyl peptidase IV
Therapy Area/IndicationsDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSanofi Aventis
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSanofi Aventis
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus, Type 2

Other Information

ATC CodeN/A
Related LinksN/A